Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatoce

Introduction

Hepatocellular carcinoma (HCC) is a major global health concern characterized by high incidence and mortality rates, imposing heavy burdens on patients and healthcare systems alike.1,2 Over 800,000 cases are reported annually…

Continue Reading